Stock NUTX NUTEX HEALTH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Nutex Health Inc.

Equities

NUTX

US67079U2078

End-of-day quote Nasdaq
Other stock markets
 06:00:00 2024-06-30 pm EDT 		5-day change 1st Jan Change
0.5902 USD -0.79% Intraday chart for Nutex Health Inc. +3.91% -78.14%
Jun. 27 Nutex Health to Implement 1-for-10 Reverse Stock Split MT
Jun. 24 Nutex Health Inc.(NasdaqCM:NUTX) dropped from S&P Global BMI Index CI

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.

Strengths

  • Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
  • For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company has insufficient levels of profitability.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
NUTEX HEALTH INC. Stock Nutex Health Inc.
-78.14% 293M -
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+18.11% 83.73B
C+
CVS HEALTH CORPORATION Stock CVS Health Corporation
-27.15% 72.21B
B-
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
-1.13% 26.2B
C+
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-10.81% 17.09B
B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+1.21% 17.18B
A-
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-0.90% 15.18B
A-
NATERA, INC. Stock Natera, Inc.
+76.72% 13.59B
C-
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+77.64% 13.11B
C+
PURE HEALTH HOLDING Stock Pure Health Holding
-25.09% 12.92B - -
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
-
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
  1. Stock Market
  2. Equities
  3. NUTX Stock
  4. Ratings Nutex Health Inc.